These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1677567)

  • 21. Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells.
    Van Sande J; Costa MJ; Massart C; Swillens S; Costagliola S; Orgiazzi J; Dumont JE
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5366-74. PubMed ID: 14602775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody.
    Zakarija M; McKenzie JM
    Endocrinology; 1980 Dec; 107(6):2051-4. PubMed ID: 6107244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M; Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenylate cyclase activity and the accumulation and release of adenosine 3',5'-monophosphate in normal human thyroid tissue slice preparations: responses to thyrotropin and thyroid-stimulating antibodies.
    Bidey SP; Marshall NJ; Ekins RP
    J Clin Endocrinol Metab; 1981 Aug; 53(2):246-53. PubMed ID: 6114107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
    Tahara K; Yamamoto K; Tamura Y; Yoshida S
    Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.
    Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR
    Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site.
    Piraphatdist T; Sugawa H; Inoue D; Enomoto T; Mori T; Imura H
    Biochem Biophys Res Commun; 1990 Oct; 172(2):529-36. PubMed ID: 1978673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of metabolic activity of polymorphonuclear granulocytes by thyroid stimulating antibodies.
    Balázs C; Bokk A; Kiss E
    J Endocrinol Invest; 1992 Jun; 15(6):465-9. PubMed ID: 1357025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
    Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid stimulating activity of rabbit antibodies toward the human thyrotropin receptor peptide.
    Endo T; Ohmori M; Ikeda M; Onaya T
    Biochem Biophys Res Commun; 1991 May; 177(1):145-50. PubMed ID: 2043101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol.
    Kasagi K; Konishi J; Arai K; Misaki T; Iida Y; Endo K; Torizuka K
    J Clin Endocrinol Metab; 1986 May; 62(5):855-62. PubMed ID: 2870075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of the antibody response to the extracellular region of recombinant thyrotropin receptor.
    Morgenthaler NG; Kim MR; Gardas A; Vlase H; Aust G; Gupta M; McGregor AM; Banga JP
    Autoimmunity; 1997; 26(2):75-84. PubMed ID: 9546816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
    Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
    Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S; Ban T; Kohn LD
    Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.